Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

A Rare Presentation of Acute Immune Thrombocytopenia, Refractory to First Line Therapy, Despite Euthyroid State

Emily Molina, DO, MSPH, Gursharon Sanghera, MD, Patrick Hanley, MD, Rafat Ahmed, MD

Blood (2019) 134 (Supplement_1): 4900.

https://doi.org/10.1182/blood-2019-126200

Published: 2019

Journal Articles

The Location of CD4 + FoxP3 + Cells with Regard to CD25 and TNFRSF25 Receptor Signals Matters: Different Requirements for GI and Peripheral Tregs

Casey O. Lightbourn, MS, Clarisel Lozano, Cameron S. Bader, BS, Sabrina N. Copsel, PhD, Dietlinde Wolf, PhD, Henry Barreras, MPH, Robert B. Levy, PhD

Blood (2019) 134 (Supplement_1): 1920.

https://doi.org/10.1182/blood-2019-131076

Published: 2019

Journal Articles

Primary Ocular Lymphoma: A SEER Database Analysis of Patterns of Involvement and Outcomes

Arushi Khurana, MBBS, Taha Al-Juhaishi, MD, Victor Yazbeck, MD, Danielle Shafer, DO

Blood (2019) 134 (Supplement_1): 4013.

https://doi.org/10.1182/blood-2019-132011

Published: 2019

Journal Articles

Low Molecular Weight Heparin (LMWH) for Venous Thromboembolism (VTE) Prophylaxis in Patients with Primary Central Nervous System Lymphoma (PCNSL)

Deborah Rund, MD, Stav Gazal, BSc, Yosef Kalish, MD, Chen Makranz, MD, Neta Goldschmidt, MD

Blood (2018) 132 (Supplement 1): 2993.

https://doi.org/10.1182/blood-2018-99-119154

Published: 2018

Journal Articles

Genetic Landscape of Ocular Adnexa Extranodal Marginal Zone Lymphoma

Marco Magistri, PhD MS, Lanie Happ, Jeremy Ramdial, MD, Kranthi Kunkalla, Sander R Dubovy, MD, Jennifer R Chapman, MD, Francisco Vega, MD PhD, Sandeep Dave, MD, Izidore S. Lossos, MD

Blood (2018) 132 (Supplement 1): 923.

https://doi.org/10.1182/blood-2018-99-111325

Published: 2018

Journal Articles

Efficacy of Radiation Treatement in Ocular Adnexa Mucosa-Associated Lymphoid Tissue Lymphoma: A Retrospective Evaluation in a Single Center Experience

Dario Marino, MDPhD, Maital Bolshinsky, MD, Silvia Finotto, MD, Raffaele Parrozzani, MD, Caterina Boso, MD, Federica Vianello, MD, Edoardo Midena, MD, Luca Canziani, MD, Laura Evangelista, MD, Vittorina Zagonel, MD

Blood (2017) 130 (Supplement 1): 2781.

https://doi.org/10.1182/blood.V130.Suppl_1.2781.2781

Published: 2017

Journal Articles

Treatment of Bilateral Synchronous Ocular Adnexa Marginal Zone Lymphoma: Consortium for Improving Survival of Lymphoma (CISL) Study

Sung Yong Oh, Jin Seok Kim, MD PhD, Ji Hyun Lee, MD PhD, Won Seog Kim, MD, Ph. D., Seok Jin Kim, MD PhD, Dok Hyun Yoon, MD PhD, Jung Yong Hong, Won-Sik Lee, MD, Hyo Jung Kim, MD PhD, Jong-Ho Won, MD, Byeong Park, MD, Soon Il Lee, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 5155.

https://doi.org/10.1182/blood.V130.Suppl_1.5155.5155

Published: 2017

Journal Articles

R-CVP Chemoimmunotherapy for Limited-Stage Ocular Adnexal MALT Lymphoma with Adverse Factors: A Phase II Study

Sung-Yong Kim, MD, Seok-Goo Cho, Won-Sik Lee, MD, Suk-Woo Yang, MD, Sung Yong Oh, MD, Hee Bae Ahn, MD, Deok-Hwan Yang, Seong Kyu Park, Jee Ho Chang, MD, Hyo Jung Kim, MD PhD, Min Joung Lee, Jae Wook Yang

Blood (2016) 128 (22): 2981.

https://doi.org/10.1182/blood.V128.22.2981.2981

Published: 2016

Journal Articles

A Novel Prognostic Index for Ocular Adnexal Lymphoma

Marshall W. Meeks, BS, Henry S. Park, MD MPH, James B. Yu, MD MHS, Kenneth B. Roberts, MD, Francine Foss, MD, Lynn D. Wilson, MD MPH

Blood (2016) 128 (22): 3597.

https://doi.org/10.1182/blood.V128.22.3597.3597

Published: 2016

Journal Articles

Chemotherapy Alone Is Effective to Treat Localized and Disseminated Ocular Adnexa Lymphomas

Wei-Li Ma, MD

Blood (2015) 126 (23): 2709.

https://doi.org/10.1182/blood.V126.23.2709.2709

Published: 2015

Journal Articles

Local Control of Ocular Adnexal Lympho-Proliferative Disorders (OALD): Similar Outcomes in MALT and Non-MALT Histologies

Binod Dhakal, MD, Sridevi Ramalingam, MD, Jamie Shuff, MD, Narendranath Epperla, MD, Lisa Rein, MS, Anjishnu Banerjee, PhD, Malika Siker, MD, Paul R. Hosking, MD, Parameswaran Hari, MD MRCP, MS, Anita D'Souza, MBBS, MD, Ehab Atallah, MD, Beth Erisckson, MD, Timothy S. Fenske, MD, Mehdi Hamadani, MD

Blood (2015) 126 (23): 2711.

https://doi.org/10.1182/blood.V126.23.2711.2711

Published: 2015

Journal Articles

Diagnostic Value of Minor Salivary Glands Biopsy in Systemic Amyloidosis

Giacinto La Verde, Maria Paola Bianchi, Giusy Antolino, Giulia Galassi, Francescaromana Festuccia, Giorgio Bandiera, Armando Bartolazzi, Paolo Menè, Agostino Tafuri, MD

Blood (2015) 126 (23): 5381.

https://doi.org/10.1182/blood.V126.23.5381.5381

Published: 2015

Journal Articles

Pharmacokinetics of Intravenous Infusion of Glu-Plasminogen Concentrate in Patients with Hypoplasminogenemia

Brandon M. Hardesty, MD, Stacy Plum, PhD, Karen Thibaudeau, PhD, Martin Lee, PhD, Amy D. Shapiro, MD

Blood (2015) 126 (23): 3498.

https://doi.org/10.1182/blood.V126.23.3498.3498

Published: 2015

Journal Articles

Clinical Manifestations and Treatment Results in Accordance with Frontline Treatment Modalities for Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma (OAML)

Young-Woo Jeon, Jae-Ho Yoon, MD, Sung-Eun Lee, MD, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, MD, Seok Lee, Chang-Ki Min, MD, Jong Wook Lee, Woo-Sung Min, MD, Seok-Goo Cho, MD

Blood (2015) 126 (23): 1522.

https://doi.org/10.1182/blood.V126.23.1522.1522

Published: 2015

Journal Articles

The Bleeding Risk of Vitamin K Antagonists Hardly Increases after the Age of 80 Years: Data from a Large Real-Life Cohort Study

Hilde Kooistra, MD, Agneta Calf, MD, Margriet Piersma-Wichers, MD, Gerbrand Izaks, MD, Nic Veeger, MSc, Karina Meijer, MD PhD

Blood (2015) 126 (23): 891.

https://doi.org/10.1182/blood.V126.23.891.891

Published: 2015

Journal Articles

Case Report: Autoimmune Hemolytic Anemia with Venous Thromboembolism, a Common Complication of a Rare Disease

Sonikpreet Sonikpreet, Gulshan Oberoi, Sarwan Kumar

Blood (2014) 124 (21): 4869.

https://doi.org/10.1182/blood.V124.21.4869.4869

Published: 2014

Journal Articles

Safety and Efficacy of Ruxolitinib in Patients with Low Platelets Enrolled in a Phase 3b Expanded-Access Study in Myelofibrosis (MF)

Martin Griesshammer, MD, Alessandro M. Vannucchi, MD, Philipp le Coutre, MD, Renato S Tavares, MD, Haifa Kathrin Al-Ali, MD, Pia Raanani, MD, Vikas Gupta, MD FRCP, FRCPath, Lynda M Foltz, MD FRCP, Pilar Giraldo, Catherine Bouard, Julian Perez Ronco, MD MBA, Jagannath Ghosh, Bruno Martino, MD

Blood (2014) 124 (21): 1859.

https://doi.org/10.1182/blood.V124.21.1859.1859

Published: 2014

Journal Articles

Greater Total Dose and Duration of Treatment with Bortezomib Are Associated with Higher Incidence of Chalazion and Other Ocular Side Effects

Karuna Ganesh, MBBChir, PhD, Connie Batlevi, MD PhD, Zhigang Zhang, PhD, Hani Hassoun, MD, Nikoletta Lendvai, MD PhD, Heather Landau, MD, Craig H. Moskowitz, MD, Philip Caron, MD PhD, Robert Motzer, MD, Sergio A Giralt, MD, Paul Hamlin, MD, Stuart M. Lichtman, MD, Matthew J. Matasar, MD MS, Carol S Portlock, MD, Neerav Shukla, MD, Carol Wasserheit-Lieblich, MD, Andrew D. Zelenetz, MD PhD, John F. Gerecitano, MD PhD

Blood (2014) 124 (21): 3487.

https://doi.org/10.1182/blood.V124.21.3487.3487

Published: 2014

Journal Articles

Recruitment Of T Cells and Macrophages To The Eyes In Recipients Of Allogeneic Hematopoietic Stem Cell Transplants Correlate With Inflammatory Cytokine Presence In Ocular Gvhd

Samantha Herretes, M.D., Juan C. Murillo, M.D., Duncan Ross, Ph.D., Tan Yaohong, M.D., Henry Barreras, B.S., Ali M. Saeed, B.S., Krishna V. Komanduri, M.D., Victor L. Perez, M.D., Robert B. Levy, Ph.D.

Blood (2013) 122 (21): 2012.

https://doi.org/10.1182/blood.V122.21.2012.2012

Published: 2013

Journal Articles

Extramedullary Disease In Waldenstrom’s Macroglobulinemia

Ranjit Banwait, MA, Yosra Aljawai, MS, Joseph Cappuccio, Serena McDiarmid, Salomon Manier, MD, Steven Peter Treon, MD, MA, PhD, Irene M. Ghobrial, MD

Blood (2013) 122 (21): 1773.

https://doi.org/10.1182/blood.V122.21.1773.1773

Published: 2013

NARROW

A Rare Presentation of Acute Immune Thrombocytopenia, Refractory to First Line Therapy, Despite Euthyroid State

The Location of CD4 + FoxP3 + Cells with Regard to CD25 and TNFRSF25 Receptor Signals Matters: Different Requirements for GI and Peripheral Tregs

Primary Ocular Lymphoma: A SEER Database Analysis of Patterns of Involvement and Outcomes

Low Molecular Weight Heparin (LMWH) for Venous Thromboembolism (VTE) Prophylaxis in Patients with Primary Central Nervous System Lymphoma (PCNSL)

Genetic Landscape of Ocular Adnexa Extranodal Marginal Zone Lymphoma

Efficacy of Radiation Treatement in Ocular Adnexa Mucosa-Associated Lymphoid Tissue Lymphoma: A Retrospective Evaluation in a Single Center Experience

Treatment of Bilateral Synchronous Ocular Adnexa Marginal Zone Lymphoma: Consortium for Improving Survival of Lymphoma (CISL) Study

R-CVP Chemoimmunotherapy for Limited-Stage Ocular Adnexal MALT Lymphoma with Adverse Factors: A Phase II Study

A Novel Prognostic Index for Ocular Adnexal Lymphoma

Chemotherapy Alone Is Effective to Treat Localized and Disseminated Ocular Adnexa Lymphomas

Local Control of Ocular Adnexal Lympho-Proliferative Disorders (OALD): Similar Outcomes in MALT and Non-MALT Histologies

Diagnostic Value of Minor Salivary Glands Biopsy in Systemic Amyloidosis

Pharmacokinetics of Intravenous Infusion of Glu-Plasminogen Concentrate in Patients with Hypoplasminogenemia

Clinical Manifestations and Treatment Results in Accordance with Frontline Treatment Modalities for Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma (OAML)

The Bleeding Risk of Vitamin K Antagonists Hardly Increases after the Age of 80 Years: Data from a Large Real-Life Cohort Study

Case Report: Autoimmune Hemolytic Anemia with Venous Thromboembolism, a Common Complication of a Rare Disease

Safety and Efficacy of Ruxolitinib in Patients with Low Platelets Enrolled in a Phase 3b Expanded-Access Study in Myelofibrosis (MF)

Greater Total Dose and Duration of Treatment with Bortezomib Are Associated with Higher Incidence of Chalazion and Other Ocular Side Effects

Recruitment Of T Cells and Macrophages To The Eyes In Recipients Of Allogeneic Hematopoietic Stem Cell Transplants Correlate With Inflammatory Cytokine Presence In Ocular Gvhd

Extramedullary Disease In Waldenstrom’s Macroglobulinemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only